title: CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
abstract: The California Institute for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) have similar objectives, but their histories, funding mechanisms, and governance could hardly be more different. Here, we compare the two programs and explore their impact in translating stem cell research into clinical applications.
authors.affiliation: Institute for Stem Cell Biology and Regenerative Medicine and Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, 265 Campus Drive West, Room G3167, Stanford, CA 94305-5461, USA. Electronic address: irv@stanford.edu.
authors.forename: Irving L
authors.initials: IL
authors.lastname: Weissman
authors.affiliation: King's College London Centre for Stem Cells and Regenerative Medicine, Floor 28, Tower Wing, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, UK. Electronic address: fiona.watt@kcl.ac.uk.
authors.forename: Fiona M
authors.initials: FM
authors.lastname: Watt
mesh_terms: D002140:California; D003299:Cooperative Behavior; D007449:Investments / Q000191:economics*; D044968:Regenerative Medicine / Q000191:economics*; D057905:Stem Cell Research / Q000191:economics; D057170:Translational Research, Biomedical / Q000191:economics; D006113:United Kingdom